Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Xingyi Kuang"'
Autor:
Kunlin Yu, Jishi Wang, Xu Liu, Qin Fang, Xingyi Kuang, Jie Xiong, Depei Wu, Weili Wang, Tingting Lu, Lu Zhao, Zhaoyuan Zhang
Publikováno v:
Cancer Gene Therapy. 28:265-278
Multiple myeloma (MM) is still an incurable hematological malignancy, with even poorer prognosis in MM patients with distant invasion. The present study was designed to explore the effects of C3a and C5a on the migration, invasion, and adhesion of MM
Publikováno v:
Am J Cancer Res
CD8(+) T cells are crucial adaptive immune effectors and express receptors (T cell receptors, TCRs) that specifically recognize and eradicate tumor cells. The diversity of the TCR repertoire is generated by specialized genetic diversification mechani
Background: CD8+ T cells are crucial adaptive immune effectors and express receptors (T cell receptors, TCRs) that specifically recognize and eradicate tumor cells. The diversity of the TCR repertoire is generated by specialized genetic diversificati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::391a9965419363e4cc2070a5fa9eb440
https://doi.org/10.21203/rs.3.rs-50231/v1
https://doi.org/10.21203/rs.3.rs-50231/v1
Publikováno v:
International Journal of Medical Sciences
Deubiquitylating enzyme ubiquitin-specific protease 1 (USP1) has been reported to be aberrantly overexpressed in cancers, and it plays a critical role in regulating various cellular processes, such as cell proliferation, apoptosis, and cell different
Autor:
Kunling Yu, Sishi Tang, Jishi Wang, Xingyi Kuang, Weili Wang, Bo Hu, Bingqing Cheng, Qing Fang, Dan Ma
Publikováno v:
Experimental Cell Research. 363:196-207
Inhibition of histone deacetylase (HDAC) is a promising therapeutic strategy for various hematologic cancers. Panobinostat has been approved for treating patients with multiple myeloma (MM) by the FDA. Since the mechanism for the resistance of panobi
Autor:
Xingyi Kuang, Jie Xiong, Jishi Wang, Dan Ma, Qin Fang, Zhaoyuan Zhang, Weili Wang, Siyu Zhang
Publikováno v:
Aging (Albany NY)
Chemoresistance is still a critical challenge for efficient treatment of multiple myeloma (MM) during the bortezomib-based chemotherapy. Recent studies have suggested that heme oxygenase-1 (HO-1) is involved in apoptosis, proliferation and chemoresis
Autor:
Qin Fang, Xu Liu, Kunlin Yu, Tingting Lu, Weili Wang, Xingyi Kuang, Jishi Wang, Lu Zhao, Zhaoyuan Zhang, Jie Xiong, Depei Wu
Publikováno v:
Cancer Gene Therapy. 28:1227-1227
Publikováno v:
International Journal of Oncology. 49:1921-1930
miR-378 has been proven to inhibit cell growth, migration and invasion in different types of cancers. In this study, we found that miR-378 was commonly downregulated in the bone marrow cells obtained from myelodysplastic syndrome (MDS) patients. We f
Publikováno v:
Hematology. 21:593-602
Myelodysplastic syndromes (MDS) include a heterogeneous group of clonal hematological stem cell disorders characterized by ineffective hematopoiesis, cytopenias. MicroRNAs (miRNAs) are short non-coding RNA molecules that repress gene expression at th
Autor:
Bingqing Cheng, Zhaoyuan Zhang, Jishi Wang, Weili Wang, Qin Fang, Xu Liu, Xinyao Li, Jie Xiong, Depei Wu, Tingting Lu, Danna Wei, Xingyi Kuang
Publikováno v:
Journal of Cancer
OBJECTIVE: Fenretinide is reported to induce NR4A1-associated apoptosis in several types of cancer cells. However, it remains unclear about its specific role and the underlying mechanism in acute myeloid leukemia (AML). Therefore, this study aimed to